PER.C6

Welcome to the Brand page for “PER.C6”, which is offered here for Treatment of cells, chemical solutions, dna delivery vehicles, proteinaceaous molecules and nucleic acids for use in the preparation of pharmaceuticals and/or genetic biochemicals;cells, cell-lines and culture media for the cultivation of cells, for medical or clinical use, pharmaceutical products, viruses, viral vectors, therapeutic proteins and vaccines;per.c six;the applicant claims color as a feature of the mark, ---, ---, ---.;scientific services, research in the medical and biochemical field, the examination and testing of genes, phamaceutical and biomedical semi-finished products, test systems for cells and cell-lines; culture media for cultivation of cells and cell-lines; genetically modified materials for the development of medicines, gene banks and diagnostic purposes, services for third parties for preparation and production of unfinished pharmaceutical products, cell line generation and cell banking;.

Its status is currently believed to be active. Its class is unavailable. “PER.C6” is believed to be currently owned by “CRUCELL HOLLAND B.V.”


Owner:
CRUCELL HOLLAND B.V.
Owner Details
Description:
Treatment of cells, chemical solutions, DNA delivery vehicles, proteinaceaous molecules and nucleic acids for use in the preparation of pharmaceuticals and/or genetic biochemicals;Cells, cell-lines and culture media for the cultivation of cells, for medical or clinical use, pharmaceutical products, viruses, viral vectors, therapeutic proteins and vaccines;PER.C SIX;The applicant claims color as a feature of the mark, ---, ---, ---.;Scientific services, research in the medical and biochemical field, the examination and testing of genes, phamaceutical and biomedical semi-finished products, test systems for cells and cell-lines; culture media for cultivation of cells and cell-lines; genetically modified materials for the development of medicines, gene banks and diagnostic purposes, services for third parties for preparation and production of unfinished pharmaceutical products, cell line generation and cell banking;
Categories: TREATMENT CELLS